Elevated levels of pro-inflammatory biomarkers, including interleukins, TNF-α, CRP, and serum amyloid A, have been consistently observed in IBD patients and are closely associated with increased atherosclerosis and heightened CV risk [251,252,253]. This evidence concerns the gene TNF and atherosclerosis.